NCT04124900View on ClinicalTrials.gov

Telomere Associated Variables (TAVs) in Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

509

Participants

Timeline

Start Date

July 15, 2019

Primary Completion Date

July 31, 2023

Study Completion Date

September 21, 2023

Conditions
Prostate Cancer
Trial Locations (10)

14004

University Hospital Reina Sofía, Córdoba

14940

Hospital Infanta Margarita, Cabra

28010

ROC Clinic, Madrid

28020

Instituto de Urología LYX, Madrid

28034

Hospital Universitario Ramón y Cajal, Madrid

28041

Hospital Universitario Doce de Octubre, Madrid

33016

Urological Research Network, Corp., Hialeah

46009

Instituto Valenciano de Oncología, Valencia

77030

Houston Methodist Research Institute, Houston

08024

Instituto Médico Tecnológico, Barcelona

All Listed Sponsors
lead

Life Length SL

INDUSTRY

NCT04124900 - Telomere Associated Variables (TAVs) in Prostate Cancer | Biotech Hunter | Biotech Hunter